Genetic deletion of the P2Y2 receptor offers significant resistance to development of lithium-induced polyuria accompanied by alterations in PGE2 signaling

American Journal of Physiology - Renal Physiology

Volumn 302, Issue 1, 2012, Pages 70-77

  Zhang, Yue ^a,c   Pop, Ioana L ^a,c   Carlson, Noel G ^b,c   Kishore, Bellamkonda K ^a,c  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b Desert Pacific Healthcare Network   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Aquaporin 2; ATP; Vasopressin

Indexed keywords

AQUAPORIN 2; ARGIPRESSIN; CYCLIC AMP; LITHIUM; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E2; PURINERGIC P2Y2 RECEPTOR; LITHIUM CHLORIDE; PROSTAGLANDIN E RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; GENE DELETION; KIDNEY MEDULLA; LITHIUM INDUCED POLYURIA; MOUSE; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; POLYURIA; PRIORITY JOURNAL; URINARY EXCRETION; URINE OSMOLALITY; ANIMAL; CHEMICALLY INDUCED DISORDER; FEMALE; KIDNEY COLLECTING TUBULE; MALE; METABOLISM; MOUSE MUTANT; URINE;

ANIMALS; AQUAPORIN 2; ARGININE VASOPRESSIN; CYCLIC AMP; DIABETES INSIPIDUS, NEPHROGENIC; DINOPROSTONE; FEMALE; KIDNEY TUBULES, COLLECTING; LITHIUM CHLORIDE; MALE; MICE; MICE, KNOCKOUT; POLYURIA; RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; RECEPTORS, PURINERGIC P2Y2;

EID: 83455242880     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00444.2011     Document Type: Article

References (27)

1. Allen HM, Jackson RL, Winchester MD, Deck LV, Allon M. Indomethacin in the treatment of lithium-induced nephrogenic diabetes insipidus. Arch Intern Med 149: 1123-1126, 1989.
2. Christensen BM, Zuber AM, Loffing J, Stehle JC, Deen PMT, Rossier BC, Hummler E. α-ENaC-mediated lithium absorption promotes nephrogenic diabetes insipidus. J Am Soc Nephrol 22: 253-261, 2011.
3. Cressman VL, Lazarowski E, Homolya L, Boucher RC, Koller BH, Grubb BR. Effect of loss of P2Y2 receptor gene expression on nucleotide regulation of murine epithelial Cl- transport. J Biol Chem 274: 26461-26468, 1999.
4. Ecelbarger CM, Zhang Y, Garikepati M, Kishore BK. Role of purinergic P2Y2 receptor (P2Y2-R) in the regulation of the renal epithelial sodium channel (ENaC) and other sodium transporters in lithium-treated mice (Abstract). FASEB J 25: 1039.24, 2011.
5. Fernández-Llama P, Ecelbarger CA, Ware JA, Andrews P, Lee AJ, Turner R, Nielsen S, Knepper MA. Cyclooxygenase inhibitors increase Na-K-2Cl cotransporter abundance in thick ascending limb of Henle's loop. Am J Physiol Renal Physiol 277: F219-F226, 1999.
6. Grünfeld JP, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol 5: 270-276, 2009.
7. Hansen J, Haenelt M, Gross P. Lithium induced polyuria and renal vasopressin receptor density. Nephrol Dial Transplant 11: 622-627, 1996.
8. Hao CM, Breyer MD. Physiological regulation of prostaglandins in the kidney. Annu Rev Physiol 70: 357-377, 2008.
9. Hirschowitz J, Kolevzon A, Garakani A. The pharmacological treatment of bipolar disorder: the question of modern advances. Harv Rev Psychiatry 18: 266-278, 2010.
10. Homolya L, Watt WC, Lazarowski ER, Koller BH, Boucher RC. Nucleotide-regulated calcium signaling in lung fibroblasts and epithelial cells from normal and P2Y2 receptor (-/-) mice. J Biol Chem 274: 26454-26460, 1999.
11. Judge JP, Kohan DE, Carlson NG, Nelson RD, Kishore BK. Mice with genetic deletion of P2Y2 receptor are markedly resistant to lithiuminduced polyuria (Abstract). J Am Soc Nephrol 17: 31A, 2006.
12. Kim GH, Choi NW, Jung JY, Song JH, Lee CH, Kang CM, Knepper MA. Treating lithium-induced nephrogenic diabetes insipidus with COX-2 inhibitor improves polyuria via upregulation of AQP2 and NKCC2. Am J Physiol Renal Physiol 294: F702-F709, 2008.
13. Kishore BK, Krane CM, DiIulio D, Menon AG, Cacini W. Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria. Kidney Int 58: 701-711, 2000.
14. Kishore BK, Nelson RD, Kohan DE, Carlson NG, Zhang Y. Characterization of resistance of P2Y2 receptor knockout mice to lithium-induced nephrogenic diabetes insipidus (Abstract). J Am Soc Nephrol 20: 827A, 2009.
15. Kishore BK, Nelson RD, Miller RL, Carlson NG, Kohan DE. P2Y2 receptors and water transport in the kidney. Puriner Signal 5: 491-499, 2009.
16. Kortenoeven MLS, Li Y, Shaw S, Gaeggeler HP, Rossier BC, Wetzels JFM, Deen PMT. Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus. Kidney Int 76: 44-53, 2009.
17. Li Y, Shaw S, Kamsteeg EJ, Vandewalle A, Deen PMT. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity. J Am Soc Nephrol 17: 1063-1072, 2006.
18. Mitchell PB, Malhi GS. Emerging drugs for bipolar disorders. Expert Opin Emerg Drugs 11: 621-634, 2006.
19. Nivoli AM, Murru A, Vieta E. Lithium: still a cornerstone in the long-term treatment in bipolar disorder? Neuropsychobiology 62: 27-35, 2010.
20. Quiroz JA, Machado-Viera R, Zarate CA Jr. Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology 62: 50-60, 2010.
21. + and water reabsorption. FASEB J 21: 3717-3726, 2007.
22. Sugawara M, Hashimot K, Ota Z. Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria. Am J Physiol Regul Integr Comp Physiol 254: R863-R869, 1988.
23. Trepiccione F, Christensen BM. Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings. J Nephrol 16: S43-S48, 2010.
24. Usberti M, Dechaux M, Guillot M, Sekugmann R, Pavlovitch H, Loirat C, Sachs C, Broyer M. Renal prostaglandin E2 in nephrogenic diabetes insipidus: effects of inhibition of prostaglandin synthesis by indomethacin. J Pediatr 97: 476-478, 1980.
25. Zhang Y, Kohan DE, Nelson RD, Carlson NG, Kishore BK. Potential involvement of P2Y2 receptor in diuresis of postobstructive uropathy in rats. Am J Physiol Renal Physiol 298: F634-F642, 2010.
26. Zhang Y, Nelson RD, Carlson NG, Kamerath CD, Kohan DE, Kishore BK. Potential role of purinergic signaling in lithium-induced neprhogenic diabetes insipidus. Am J Physiol Renal Physiol 296: F1194-F1201, 2009.
27. Zhang Y, Sands JM, Kohan DE, Kohan DE, Nelson RD, Martin CF, Carlson NG, Kamerath CD, Ge Y, Klein JD, Kishore BK. Potential role of purinergic signaling in urinary concentration in inner medulla: insights from P2Y2 receptor gene knockout mice. Am J Physiol Renal Physiol 295: F1715-F1724, 2008.